At the inflammatory level, the treatment of CCl4-rats with SIL, GNPs, and SGNPs significantly declined the high hepatic TGF-β1 level with the best effect in the rats treated with SIL and SGNP. This evidence concerns the gene TGFB1 and squamous cell intraepithelial neoplasia.